Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Marina Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Marina Biotech Acquires Prestalia from Symplmed Pharma 12
Marina Biotech to Acquire Intranasal Ketamine Program from Turing Pharma 13
Venture Financing 14
Marina Biotech Raises USD0.3 Million in Financing Round 14
Partnerships 15
Rosetta Genomics And Marina Biotech Enter Into Agreement To Develop MicroRNA Diagnostics 15
Marina Biotech Enters Into Co-Development Agreement With Girindus 17
Merger 18
Marina Biotech and IthenaPharma Merges 18
Licensing Agreements 19
Marina Biotech Enters into Development and Licensing Agreement with Autotelic 19
Oncotelic Enters into Licensing Agreement with Marina Biotech 20
LipoMedics Enters into Licensing Agreement Marina Biotech for SMARTICLES 21
Autotelic Enters into Licensing Agreement with Marina Biotech 22
Marina Biotech Enters into Licensing Agreement with Autotelic 23
Marina Biotech Enters into Licensing Agreement for NOV582 24
Marina Biotech Exercises Option for Licensing Agreement for Smarticles and DiLA2 Platform 25
Hongene Biotech Enters into Licensing Agreement with Marina Biotech 26
Marina Biotech Enters into Licensing Agreement with MiNA Therapeutics 27
Marina Biotech Amends Licensing Agreement with Mirna Therapeutics for MicroRNA Therapeutics 28
Arcturus Therapeutics Enters Into Licensing Agreement With Marina Biotech For Unlocked Nucleobase Analog Technology 30
Marina Biotech Enters Into Licensing Agreement With Tekmira Pharma For RNAi Technology 31
Marina Biotech Enters Into Licensing Agreement With Novartis For CRN Technology 32
Marina Biotech Enters Into Licensing Agreement With ProNAi Therapeutics For DNAi Therapeutics 33
Equity Offering 34
Marina Biotech Raises USD11.7 Million in Private Placement 34
Marina Biotech Raises USD0.3 Million in Private Placement of Shares 35
Marina Biotech Raises USD1 Million in Private Placement of Preferred Stock and Warrants 36
Marina Biotech Raises USD6 Million in Private Placement Of Shares 37
Marina Biotech Raises USD1.2 Million in Private Placement of Shares and Warrants 38
Marina Biotech Completes Private Placement Of Shares For US$2 Million 39
Marina Biotech Completes Private Placement Of Redeemable Preferred Stock For US$5 Million 40
Debt Offering 41
Marina Biotech to Raise USD0.5 Million in Private Placement of Notes Due 2018 41
Marina Biotech Raises USD0.2 Million in Private Placement of 5% Notes Due 2018 42
Marina Biotech Raises USD0.1 Million in Issue of Convertible Promissory Notes 43
Asset Transactions 44
Marina Biotech to Sell DiLA2 Delivery Platform for USD1.5 Million 44
Marina Biotech Inc – Key Competitors 45
Marina Biotech Inc – Key Employees 46
Marina Biotech Inc – Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Recent Developments 48
Corporate Communications 48
Jun 29, 2018: Marina Biotech Names Uli Hacksell And Robert C. Moscato As Board Directors 48
Jun 20, 2018: Marina Biotech Appoints Robert Moscato to Chief Executive Officer 49
Jul 05, 2017: Marina Biotech Announces the Appointment of Dr. Vuong Trieu as Executive Chairman 50
Jun 26, 2017: Marina Biotech appoints chief commercial officer 51
Feb 21, 2017: Marina Biotech Appoints Dr. Seymour Fein as Chief Medical Officer 52
Feb 14, 2017: Marina Biotech Announces Key Additions to its Executive Management Team 53
Product News 54
03/13/2017: Marina Biotech to Present A Late Breaking Poster on the Safety and Tolerability of CEQ508 for FAP at the Society of Toxicology 56th Annual Meeting on March 16 54
Other Significant Developments 55
Apr 05, 2017: Marina Biotech Provides Business Update 55
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
Marina Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Marina Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Marina Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Marina Biotech Acquires Prestalia from Symplmed Pharma 12
Marina Biotech to Acquire Intranasal Ketamine Program from Turing Pharma 13
Marina Biotech Raises USD0.3 Million in Financing Round 14
Rosetta Genomics And Marina Biotech Enter Into Agreement To Develop MicroRNA Diagnostics 15
Marina Biotech Enters Into Co-Development Agreement With Girindus 17
Marina Biotech and IthenaPharma Merges 18
Marina Biotech Enters into Development and Licensing Agreement with Autotelic 19
Oncotelic Enters into Licensing Agreement with Marina Biotech 20
LipoMedics Enters into Licensing Agreement Marina Biotech for SMARTICLES 21
Autotelic Enters into Licensing Agreement with Marina Biotech 22
Marina Biotech Enters into Licensing Agreement with Autotelic 23
Marina Biotech Enters into Licensing Agreement for NOV582 24
Marina Biotech Exercises Option for Licensing Agreement for Smarticles and DiLA2 Platform 25
Hongene Biotech Enters into Licensing Agreement with Marina Biotech 26
Marina Biotech Enters into Licensing Agreement with MiNA Therapeutics 27
Marina Biotech Amends Licensing Agreement with Mirna Therapeutics for MicroRNA Therapeutics 28
Arcturus Therapeutics Enters Into Licensing Agreement With Marina Biotech For Unlocked Nucleobase Analog Technology 30
Marina Biotech Enters Into Licensing Agreement With Tekmira Pharma For RNAi Technology 31
Marina Biotech Enters Into Licensing Agreement With Novartis For CRN Technology 32
Marina Biotech Enters Into Licensing Agreement With ProNAi Therapeutics For DNAi Therapeutics 33
Marina Biotech Raises USD11.7 Million in Private Placement 34
Marina Biotech Raises USD0.3 Million in Private Placement of Shares 35
Marina Biotech Raises USD1 Million in Private Placement of Preferred Stock and Warrants 36
Marina Biotech Raises USD6 Million in Private Placement Of Shares 37
Marina Biotech Raises USD1.2 Million in Private Placement of Shares and Warrants 38
Marina Biotech Completes Private Placement Of Shares For US$2 Million 39
Marina Biotech Completes Private Placement Of Redeemable Preferred Stock For US$5 Million 40
Marina Biotech to Raise USD0.5 Million in Private Placement of Notes Due 2018 41
Marina Biotech Raises USD0.2 Million in Private Placement of 5% Notes Due 2018 42
Marina Biotech Raises USD0.1 Million in Issue of Convertible Promissory Notes 43
Marina Biotech to Sell DiLA2 Delivery Platform for USD1.5 Million 44
Marina Biotech Inc, Key Competitors 45
Marina Biotech Inc, Key Employees 46
Marina Biotech Inc, Subsidiaries 47
List of Figures
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Marina Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9